North America Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Disease Type, By Drug Class (Anti-allergic, Antiviral, Artificial Tears, and Antibiotics), By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The North America Conjunctivitis Treatment Market would witness market growth of 4.0% CAGR during the forecast period (2023-2030).

Applications extend to developing and implementing diagnostic tools and technologies for conjunctivitis. This includes creating rapid diagnostic tests, point-of-care devices, and imaging technologies that enable healthcare professionals to diagnose the cause and severity of conjunctivitis accurately. Additionally, applications extend to patient education and support programs. Various stakeholders, including healthcare providers and pharmaceutical companies, contribute to patient education regarding conjunctivitis, its treatment alternatives, and the criticality of adhering to prescribed therapies.

Furthermore, the conjunctivitis treatment market is witnessing notable trends shaping the landscape of ocular healthcare. Several emerging trends highlight advancements in treatment modalities, a focus on precision medicine, and efforts to improve patient outcomes. Increasing research in immunomodulation and the development of biological therapies are gaining attention in the conjunctivitis treatment market. Biologics and immunomodulators aim to modulate the immune response, providing targeted and effective treatment, particularly for allergic and chronic forms of conjunctivitis.

The expansion of the healthcare sector in Mexico is expected to positively influence the conjunctivitis treatment market by improving access to medical services, increasing diagnosis rates, driving demand for effective therapies. Mexico is also focusing on expanding treatment facilities, fostering innovation, promoting education and awareness, and creating growth opportunities for market stakeholders in the nation's healthcare sector. As healthcare infrastructure continues to develop and evolve in Mexico, the conjunctivitis treatment market will likely experience significant advancements and transformations in the coming years. Therefore, the expansion of the healthcare sector and increasing investments in R&D in pharmaceuticals in the region is propelling the growth of the market.

The US market dominated the North America Conjunctivitis Treatment Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,626.3 Million by 2030. The Canada market would register a CAGR of 4.5% during (2023 - 2030). Additionally, The Mexico market is showcasing a CAGR of 5% during (2023 - 2030).

Based on Disease Type, the market is segmented into Allergic Conjunctivitis, Viral Conjunctivitis, and Bacterial Conjunctivitis. Based on Drug Class, the market is segmented into Anti-allergic, Antiviral, Artificial Tears, and Antibiotics. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Novartis AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
AbbVie, Inc.
AFT Pharmaceuticals
Bausch Health Companies, Inc.
Teva Pharmaceutical Industries Ltd.

North America Conjunctivitis Treatment Market Report Segmentation

By Disease Type

Allergic Conjunctivitis
Viral Conjunctivitis
Bacterial Conjunctivitis

By Drug Class

Anti-allergic
Antiviral
Artificial Tears
Antibiotics

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Conjunctivitis Treatment Market, by Disease Type
- 1.4.2 North America Conjunctivitis Treatment Market, by Drug Class
- 1.4.3 North America Conjunctivitis Treatment Market, by Distribution Channel
- 1.4.4 North America Conjunctivitis Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Conjunctivitis Treatment Market, by Disease Type

4.1 North America Allergic Conjunctivitis Market, by Country
4.2 North America Viral Conjunctivitis Market, by Country
4.3 North America Bacterial Conjunctivitis Market, by Country

Chapter 5. North America Conjunctivitis Treatment Market, by Drug Class

5.1 North America Anti-allergic Market, by Country
5.2 North America Antiviral Market, by Country
5.3 North America Artificial Tears Market, by Country
5.4 North America Antibiotics Market, by Country

Chapter 6. North America Conjunctivitis Treatment Market, by Distribution Channel

6.1 North America Hospital Pharmacy Market, by Country
6.2 North America Retail Pharmacy Market, by Country
6.3 North America Online Pharmacy Market, by Country

Chapter 7. North America Conjunctivitis Treatment Market, by Country

7.1 US Conjunctivitis Treatment Market
- 7.1.1 US Conjunctivitis Treatment Market, by Disease Type
- 7.1.2 US Conjunctivitis Treatment Market, by Drug Class
- 7.1.3 US Conjunctivitis Treatment Market, by Distribution Channel
7.2 Canada Conjunctivitis Treatment Market
- 7.2.1 Canada Conjunctivitis Treatment Market, by Disease Type
- 7.2.2 Canada Conjunctivitis Treatment Market, by Drug Class
- 7.2.3 Canada Conjunctivitis Treatment Market, by Distribution Channel
7.3 Mexico Conjunctivitis Treatment Market
- 7.3.1 Mexico Conjunctivitis Treatment Market, by Disease Type
- 7.3.2 Mexico Conjunctivitis Treatment Market, by Drug Class
- 7.3.3 Mexico Conjunctivitis Treatment Market, by Distribution Channel
7.4 Rest of North America Conjunctivitis Treatment Market
- 7.4.1 Rest of North America Conjunctivitis Treatment Market, by Disease Type
- 7.4.2 Rest of North America Conjunctivitis Treatment Market, by Drug Class
- 7.4.3 Rest of North America Conjunctivitis Treatment Market, by Distribution Channel

Chapter 8. Company Profiles

8.1 Novartis AG
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Gilead Sciences, Inc.
- 8.2.1 Company overview
- 8.2.2 Financial Analysis
- 8.2.3 Research & Development Expenses
- 8.2.4 SWOT Analysis
8.3 GlaxoSmithKline PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Trial and Approval
- 8.3.6 SWOT Analysis
8.4 F. Hoffmann-La Roche Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 SWOT Analysis
8.5 Merck & Co., Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.6 SWOT Analysis
8.6 Boehringer Ingelheim International GmbH
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional & Segmental Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 AbbVie, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 AFT Pharmaceuticals
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
8.9 Bausch Health Companies, Inc
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 Recent strategies and developments:
  - 8.9.5.1 Acquisition and Mergers:
- 8.9.6 SWOT Analysis
8.10. Teva Pharmaceutical Industries Ltd.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 Recent strategies and developments:
  - 8.10.5.1 Product Launches and Product Expansions:
- 8.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 2 North America Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 3 North America Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 4 North America Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 5 North America Allergic Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Allergic Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Viral Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Viral Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Bacterial Conjunctivitis Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Bacterial Conjunctivitis Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 12 North America Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 13 North America Anti-allergic Market, by Country, 2019 - 2022, USD Million
TABLE 14 North America Anti-allergic Market, by Country, 2023 - 2030, USD Million
TABLE 15 North America Antiviral Market, by Country, 2019 - 2022, USD Million
TABLE 16 North America Antiviral Market, by Country, 2023 - 2030, USD Million
TABLE 17 North America Artificial Tears Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Artificial Tears Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Antibiotics Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Antibiotics Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 North America Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 North America Hospital Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Hospital Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Retail Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 26 North America Retail Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 27 North America Online Pharmacy Market, by Country, 2019 - 2022, USD Million
TABLE 28 North America Online Pharmacy Market, by Country, 2023 - 2030, USD Million
TABLE 29 North America Conjunctivitis Treatment Market, by Country, 2019 - 2022, USD Million
TABLE 30 North America Conjunctivitis Treatment Market, by Country, 2023 - 2030, USD Million
TABLE 31 US Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 32 US Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 33 US Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 34 US Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 35 US Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 36 US Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 37 US Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 38 US Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 39 Canada Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 40 Canada Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 41 Canada Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 42 Canada Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 43 Canada Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 44 Canada Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 45 Canada Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Canada Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 47 Mexico Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 48 Mexico Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 49 Mexico Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 50 Mexico Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 51 Mexico Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 52 Mexico Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 53 Mexico Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Mexico Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Rest of North America Conjunctivitis Treatment Market, 2019 - 2022, USD Million
TABLE 56 Rest of North America Conjunctivitis Treatment Market, 2023 - 2030, USD Million
TABLE 57 Rest of North America Conjunctivitis Treatment Market, by Disease Type, 2019 - 2022, USD Million
TABLE 58 Rest of North America Conjunctivitis Treatment Market, by Disease Type, 2023 - 2030, USD Million
TABLE 59 Rest of North America Conjunctivitis Treatment Market, by Drug Class, 2019 - 2022, USD Million
TABLE 60 Rest of North America Conjunctivitis Treatment Market, by Drug Class, 2023 - 2030, USD Million
TABLE 61 Rest of North America Conjunctivitis Treatment Market, by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Rest of North America Conjunctivitis Treatment Market, by Distribution Channel, 2023 - 2030, USD Million
TABLE 63 Key Information - Novartis AG
TABLE 64 Key Information - Gilead Sciences, Inc.
TABLE 65 Key Information - GlaxoSmithKline PLC
TABLE 66 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 67 Key Information - Merck & Co., Inc.
TABLE 68 Key Information - Boehringer Ingelheim International GmbH
TABLE 69 Key information - AbbVie, Inc.
TABLE 70 Key Information - AFT Pharmaceuticals
TABLE 71 key information - Bausch Health Companies, Inc.
TABLE 72 Key Information - Teva Pharmaceuticals Industries Ltd.

North America Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Disease Type, By Drug Class (Anti-allergic, Antiviral, Artificial Tears, and Antibiotics), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents